Pepinemab (VX15/2503)

pepinemab · Vaccinex, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Pepinemab (VX15/2503), covering 2024-08-22 to 2024-08-22. Get the full timeline:

Most recent: Clinical Trial Update: SEMA4D Blockade Safety and Brain Metabolic Activity in Alzheimer's Disease (AD) [Phase 1, Phase 2]